弘和仁愛醫療:2023年報
Honghe Renai Healthcare (03869) announced its 2023 annual results, with profit attributable to shareholders of 131 million yuan
According to the Zhitong Finance App, Honghe Renai Healthcare (03869) announced results for the year ended December 31, 2023, with revenue of 1,428 billion yuan (RMB, same below), up 24.9% year on year; profit attributable to company owners was 131 million yuan, loss of 481 million yuan for the same period last year; basic profit per share was 0.956 yuan. The period's results turned a loss into a profit, mainly due to an increase in hospital revenue from general hospital services provided to individual patients and an increase in deferred income from convertible bonds.
HOSPITAL CORP: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Honghe Renai Healthcare (03869.HK) plans to hold a board meeting on March 26 to approve annual results
Glonghui, March 14, 丨 Honghe Renai Healthcare (03869.HK) announced that the company will hold a board meeting on March 26, 2024 (Tuesday) to (among others) consider and (if deemed appropriate) approve the annual results and announcements of the company and its subsidiaries for the year ended December 31, 2023, and consider paying a final dividend (if any).
HOSPITAL CORP: Interim Report 2023
HOSPITAL CORP: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
Honghwa Renai Healthcare (03869.HK) held a board meeting on August 30 to consider and approve the interim results
Glonghui, August 18, 丨 Honghe Renai Healthcare (03869.HK) announced that the company will hold a board meeting on August 30, 2023 (Wednesday) to (including) consider and (if deemed appropriate) approve the unaudited interim results and releases of the company and its subsidiaries for the six months ended June 30, 2023, and consider the payment of interim dividends (if any).
HOSPITAL CORP: DATE OF BOARD MEETING
HOSPITAL CORP: POSITIVE PROFIT ALERT
Honghe Renai Medical (03869) issued a written notice to subscribers stating that it would not pay the remaining amount of early redeemed convertible bonds on or before July 31
According to the Zhitong Finance App, Honghe Renai Medical (03869) announced that due to the uncertainty of the economic environment and fierce competition in the medical industry, in order to protect the health of the company's financial cash flow, the company issued a written notice to subscribers on July 31, 2023, stating that it would not pay the remaining advance redemption amount on or before July 31, 2023. The remaining early redemption amount and interest are to be paid in two installments, of which HK$39 million will be paid on or before July 31, 2024, and HK$50 million will be paid on or before July 31, 2025. Interest will be based on convertible bond statements
Hospital Corporation of China Extends Maturity of Bond Issuances
Hospital Corporation of China (HKG:3869) plan to extend the maturity date of the convertible bonds issued to Vanguard Glory to Sept. 30, 2025 from the original maturity date of Dec. 29, 2023, accordin
Hongwa Renai Healthcare: 2022 Report
The annual revenue of Hongwa Renai Healthcare (03869.HK) increased by about 119.7% to 1,143 million yuan
Gelonghui, March 27丨Honghe Renai Medical (03869.HK) announced that for the year ending December 31, 2022, the company's revenue increased by about 119.7% to about RMB 1,143 million. A net loss of approximately RMB 529 million was recorded for the year, an increase of about RMB 166 million over the same period of net loss of approximately RMB 362 million, mainly due to an increase of RMB 132 million in losses due to changes in the fair value of convertible bonds.
Hongwa Renai Healthcare: Year ended December 31, 2022 Annual Results Announcement
Hongwa Renai Healthcare (03869.HK) plans to hold board review and approval of annual results on March 27
Glonghui, March 15 | Honghe Renai Healthcare (03869.HK) announced that the company will hold a board meeting on March 27, 2023 (Monday) to (including) consider and (if deemed appropriate) approve (if deemed appropriate) the results and releases of the company and its subsidiaries for the year ended December 31, 2022, and to consider the payment of a final dividend (if any).
Hongwa Renai Healthcare (03869): Lu Wenzuo resigns as executive director
According to the Zhitong Finance App, Honghe Renai Medical (03869) issued an announcement that Lu Wenzuo has resigned as the company's executive director due to his age, effective December 26, 2022, so that he can spend more time with his family.
Honghe Charity Medical: interim report 2022
Honghe Renai Medical (03869.HK) increases guarantees for the financing of Jinhua Hospital
Gelonhui September 27 丨 Honghe Renai Medical (03869.HK) announced that on September 27, 2022, the company entered into a guarantee agreement with the Beijing branch of the bank's Nanyang Commercial Bank (China) Co., Ltd. as the beneficiary. According to this, the company agreed to provide a company guarantee for the repayment obligation of up to RMB 50 million of the outstanding principal amount. The company guarantee is provided as collateral to allow Jinhua Hospital to obtain capital from the bank to maintain daily business operations, support its development, and further enhance its competitiveness in the healthcare industry. In particular, Jinhua Hospital plans to reserve sufficient working capital to maintain daily routine
Honghe Charity Medical: supplementary notice on the annual report for the year ended December 31, 2021
Honghe Charity Medical (03869.HK) lost about 437 million yuan in the first half of the year
03869.HK announced on Aug. 30 that for the six months ended June 30, 2022, the company's revenue was 541 million yuan, up 161.0% from a year earlier, and a loss of 437 million yuan during the period, compared with 410 million yuan in the same period last year, and a basic loss per share of 3.09 yuan. The increase in revenue is mainly due to the increase in income from general hospital services as a result of the inclusion of Shanghai Yang Si Hospital since December 6, 2021, and the increase in income from comprehensive hospital services provided by Jiande traditional Chinese Medicine Hospital to individual patients. An adjusted net profit contractor was recorded during the reporting period
No Data